mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0006 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |